organization · Reporting owner
Pioneer Pharma (Hong Kong) Co Ltd
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Stablecoin Development CorpNBY · Entity 7283 | 10% owner | June 11, 2019 | June 14, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Stablecoin Development Corp
Report date June 11, 2019 · Filed June 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,188,421 |
Reported balance
After 2019-06-11 transaction · row 1
1 source rowRow 1 · 2019-06-11 · Sale · Disposed 24,326 · Balance 5,188,421 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2019 Filed Jun 14, 2019 01:32 UTC | Stablecoin Development Corp NBY · Entity 7283 | SaleCommon Stock | 24,326 | $4.04 | $98,277.04 |
DisclosureSEC source: 0001437749-19-012009 · rdgdoc.xml · nonDerivative · entry 1 Pioneer Pharma (Hong Kong) Co Ltd · CIK 0001593301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,188,421 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.